Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:03:20 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



NeutriSci International Inc
Symbol NU
Shares Issued 178,424,267
Close 2023-05-10 C$ 0.01
Market Cap C$ 1,784,243
Recent Sedar+ Documents

NeutriSci cancels partnership with Gaia Grow

2023-05-11 16:43 ET - News Release

Also News Release (C-GAIA) Gaia Grow Corp (2)

Ackerman Subject: NeutriSci International - press release for immediate dissemination Word Document File: '\\swfile\EmailIn\20230511 133337 Attachment NeutriSci - Gaia Update Press Release May 11 2023.docx' NEUTRISCI PROVIDES UPDATE TO PRODUCT ARRANGEMENT WITH GAIA GROW CORP Vancouver, British Columbia - May 11, 2023 - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTC PINK: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, announces that further to its press release dated February 22, 2023 relating to the development of a line of products for the Canadian market with Gaia Grow Corp. ("Gaia"), it has made the decision not to proceed with the partnership at this time. Glen Rehman, CEO of NeutriSci, said, "We remain optimistic at the prospects of developing unique and effective products for the Canadian marketplace, and are continuing to work with prospective partners with a view to launching new and innovative nutraceutical products in the Canadian market." About NeutriSci International Inc. NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for its products offering co-branding as well as private label opportunities and contract manufacturing services. For more information, please visit: www.neutrisci.com. On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC. Glen Rehman CEO Tel: (403) 264-6320 investors@neutrisci.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Canjex Publishing Ltd. All rights reserved.